TABLE 5.
Diagnostic and Classification Entities Associated With MDIs and PDIs at 24 Months' Postterm Equivalent
| Diagnosis | CLD, % | MDI, % | PDI, % | N | ||
|---|---|---|---|---|---|---|
| <55 | 55–69 | <55 | 55–69 | |||
| PDA | ||||||
| No | 38 | 11 | 8 | 8 | 16 | 309 |
| Yes | 55 | 11 | 12 | 10 | 15 | 606 |
| Pneumothorax | ||||||
| No | 47 | 10 | 11 | 9 | 16 | 843 |
| Yes | 71 | 28 | 7 | 18 | 15 | 72 |
| PIE | ||||||
| No | 45 | 10 | 11 | 8 | 14 | 782 |
| Yes | 77 | 19 | 12 | 16 | 26 | 133 |
| Pulmonary hemorrhage | ||||||
| No | 49 | 11 | 11 | 9 | 16 | 889 |
| Yes | 50 | 19 | 8 | 12 | 12 | 26 |
| Respiratory group classification | ||||||
| Low Fio2 | 14 | 6 | 9 | 3 | 13 | 182 |
| PD | 49 | 13 | 10 | 11 | 16 | 341 |
| EPPD | 68 | 12 | 12 | 10 | 17 | 363 |
| NEC | ||||||
| None | 47 | 9 | 10 | 9 | 14 | 569 |
| Watch | 48 | 13 | 14 | 10 | 20 | 147 |
| Stage I | 48 | 13 | 11 | 6 | 13 | 101 |
| Stage II | 68 | 19 | 14 | 8 | 17 | 36 |
| Stage IIIa | 60 | 10 | 10 | 10 | 20 | 10 |
| Stage IIIb | 62 | 28 | 10 | 17 | 31 | 29 |
| Isolated perforation | 70 | 22 | 4 | 17 | 9 | 23 |
| ROP | ||||||
| None | 28 | 10 | 10 | 9 | 15 | 252 |
| Stage 1 | 40 | 6 | 12 | 7 | 12 | 204 |
| Stage 2 | 58 | 11 | 10 | 9 | 15 | 205 |
| Stage 3 | 72 | 17 | 12 | 12 | 21 | 229 |
| Stage 4/5 | 93 | 7 | 4 | 7 | 4 | 14 |
| Ventriculomegaly | ||||||
| No | 49 | 11 | 11 | 15 | 9 | 844 |
| Yes | 50 | 14 | 11 | 21 | 14 | 70 |
| Echolucent lesion | ||||||
| No | 49 | 11 | 11 | 9 | 15 | 871 |
| Yes | 53 | 14 | 14 | 19 | 21 | 43 |
CLD included infants with and without MV (CMV or high-frequency ventilation).